Bionano Genomics, Inc. Common Stock vs. 10x Genomics, Inc. Class A Common Stock
BNGO
Bionano Genomics, Inc. Common Stock
$1.23 +2.49%
VS TXG10x Genomics, Inc. Class A Common Stock
$76.60 -0.48%
Bionano Genomics, Inc. Common Stock and 10x Genomics, Inc. Class A Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| BNGO | TXG | |
|---|---|---|
| Market Cap | $14.13 million | $10.03 billion |
| Revenue (TTM) | $30.18 million | $616.91 million |
| Net Income (TTM) | $-32,162,000 | $-75,125,000 |
TXG leads on 2 of 3 size & scale factors.
Valuation
| BNGO | TXG | |
|---|---|---|
| Price / Book | 0.45 | 12.15 |
| Price / Sales | 0.47 | 16.26 |
BNGO leads on 2 of 2 valuation factors.
Profitability
| BNGO | TXG | |
|---|---|---|
| Net Margin | -106.58% | -12.18% |
| Return on Equity | -101.76% | -9.10% |
TXG leads on 2 of 2 profitability factors.
Risk & Sentiment
| BNGO | TXG | |
|---|---|---|
| Short Interest | 0.15% | 0.42% |
BNGO leads on 1 of 1 risk & sentiment factors.
Dig deeper: BNGO overview, BNGO financials, TXG overview, TXG financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.